SIBN Stock Price, Chart, Stats & News

SI-BONE, Inc.
Save
707.37M
Market cap
–
Current P/E
–
Forward P/E
SIBN chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 79.57% |
Operating margin | -11.11% |
Pretax margin | -9.41% |
Net margin | -9.41% |
Effective tax rate | – |
ROA | -7.93% |
ROE | -11.00% |
D/E | 0.01x |
Interest coverage ratio | -8.50x |
SIBN valuation
P/E | – |
P/S | 2.70x |
P/B | 3.01x |
P/CF | -792.16x |
P/FCF | -59.72x |
P/OCF | -792.16x |
PEG | -2.06x |
EV multiple | -68.97x |
About
SI-BONE, Inc. is a medical technology company that develops and markets specialized implantable solutions for musculoskeletal conditions affecting the sacropelvic region. These devices are utilized across the United States and internationally. Its flagship product, iFuse, is a minimally invasive surgical implant system designed to address a range of indications, including sacroiliac joint dysfunction and degeneration, adult spinal deformities, and traumatic fractures of the pelvic ring.
Similar securities
Based on sector and market capitalization
Report issue











